INVEGA TRINZA ® (paliperidone palmitate), a 3-month injection, is an atypical antipsychotic indicated for the treatment of schizophrenia in patients after they have been adequately treated

INVEGA TRINZA ® (paliperidone palmitate), a three-month injection, is an atypical anti-psychotic indicated for the treatment of schizophrenia in patients after they have been adequately treated with INVEGA SUSTENNA ® (1-month paliperidone palmitate) for at least four months.

2023年4月4日 · Invega Trinza is a prescription medicine given by injection by a healthcare professional and used to treat schizophrenia. Invega Trinza is used in people who have been treated with Invega Sustenna 1 time a month injections for at least 4 months. It is not known if Invega Trinza is safe and effective in children under 18 years of age.

Learn about INVEGA TRINZA® long-acting injectable (LAI) treatment for your adult schizophrenia patients. See full Prescribing & Safety Info, including Boxed WARNING.

INVEGA TRINZA, a 3-month injection, is an atypical antipsychotic indicated for the treatment of schizophrenia in patients after they have been adequately treated with INVEGA SUSTENNA (1-month paliperidone palmitate extended-release injectable

Discuss the risks and benefits of this medication, as well as other effective and possibly safer treatments for dementia-related behavior problems, with the doctor. This medication is used to treat a certain mental/mood disorder (schizophrenia). Paliperidone belongs to a class of drugs known as atypical antipsychotics.

2025年1月16日 · INVEGA TRINZA doses expressed as 273, 410, 546 and 819 mg of paliperidone palmitate are equal to 175, 263, 350 and 525 mg eq. of paliperidone, respectively. Prior to initiating INVEGA TRINZA, patients must be adequately treated with INVEGA SUSTENNA for …

2025年2月14日 · Detailed dosage guidelines and administration information for Invega Trinza (paliperidone palmitate). Includes dose adjustments, warnings and precautions.

2024年12月17日 · Overview: Invega Trinza is used to treat schizophrenia. It is a long-acting injection given into a muscle every three months by a health care provider. Common side effects include weight gain,...

2024年10月3日 · INVEGA TRINZA ® is available as a white to off-white sterile aqueous extended-release suspension for intramuscular injection in dose strengths of 273 mg, 410 mg, 546 mg, and 819 mg paliperidone palmitate. The drug product hydrolyzes to the active moiety, paliperidone, resulting in dose strengths of 175 mg, 263 mg, 350 mg, and 525 mg of ...